Frontiers in Oncology (Sep 2022)

MRI-based radiomics analysis for preoperative evaluation of lymph node metastasis in hypopharyngeal squamous cell carcinoma

  • Shanhong Lu,
  • Shanhong Lu,
  • Shanhong Lu,
  • Shanhong Lu,
  • Hang Ling,
  • Hang Ling,
  • Hang Ling,
  • Juan Chen,
  • Lei Tan,
  • Yan Gao,
  • Huayu Li,
  • Pingqing Tan,
  • Donghai Huang,
  • Donghai Huang,
  • Donghai Huang,
  • Donghai Huang,
  • Xin Zhang,
  • Xin Zhang,
  • Xin Zhang,
  • Xin Zhang,
  • Yong Liu,
  • Yong Liu,
  • Yong Liu,
  • Yong Liu,
  • Yitao Mao,
  • Yuanzheng Qiu,
  • Yuanzheng Qiu,
  • Yuanzheng Qiu,
  • Yuanzheng Qiu

DOI
https://doi.org/10.3389/fonc.2022.936040
Journal volume & issue
Vol. 12

Abstract

Read online

ObjectiveTo investigate the role of pre-treatment magnetic resonance imaging (MRI) radiomics for the preoperative prediction of lymph node (LN) metastasis in patients with hypopharyngeal squamous cell carcinoma (HPSCC).MethodsA total of 155 patients with HPSCC were eligibly enrolled from single institution. Radiomics features were extracted from contrast-enhanced axial T-1 weighted (CE-T1WI) sequence. The most relevant features of LN metastasis were selected by the least absolute shrinkage and selection operator (LASSO) method. Univariate and multivariate logistic regression analysis was adopted to determine the independent clinical risk factors. Three models were constructed to predict the LN metastasis status: one using radiomics only, one using clinical factors only, and the other one combined radiomics and clinical factors. Receiver operating characteristic (ROC) curves and calibration curve were used to evaluate the discrimination and the accuracy of the models, respectively. The performances were tested by an internal validation cohort (n=47). The clinical utility of the models was assessed by decision curve analysis.ResultsThe nomogram consisted of radiomics scores and the MRI-reported LN status showed satisfactory discrimination in the training and validation cohorts with AUCs of 0.906 (95% CI, 0.840 to 0.972) and 0.853 (95% CI, 0.739 to 0.966), respectively. The nomogram, i.e., the combined model, outperformed the radiomics and MRI-reported LN status in both discrimination and clinical usefulness.ConclusionsThe MRI-based radiomics nomogram holds promise for individual and non-invasive prediction of LN metastasis in patients with HPSCC.

Keywords